Acadia pharmaceuticals inc. (ACAD)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-88,023

-53,036

-41,978

-54,941

-85,304

-65,492

-62,138

-63,266

-54,296

-68,871

-65,248

-67,441

-87,843

-78,696

-71,613

-71,322

-49,762

-45,784

-38,906

-39,378

-40,375

-28,366

-24,786

-21,495

-17,828

-12,049

-10,695

-9,081

-6,123

-6,810

-2,402

-5,419

-6,218

-5,300

-5,076

-6,556

-5,833

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

22,348

19,763

22,197

20,422

19,883

20,401

20,169

20,552

20,442

22,019

19,698

18,244

15,571

15,418

14,009

13,883

11,955

8,902

9,265

7,499

14,528

4,645

3,901

4,331

3,162

2,174

1,891

1,064

582

551

488

478

413

408

401

414

375

Amortization of premiums and accretion of discounts on investment securities

-87

561

1,057

989

1,006

163

174

66

175

153

-159

184

113

56

-368

-11

234

158

787

826

289

-139

-356

322

-311

-590

-465

-328

-145

-28

5

77

79

136

-22

-68

-151

Amortization of intangible assets

400

400

400

300

400

400

400

331

369

392

370

369

369

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on strategic investment

-1,497

491

747

-12

-229

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

294

277

282

326

415

384

382

342

392

296

327

307

270

260

241

204

138

128

117

280

122

61

60

42

43

39

16

12

12

-

-

-

-

-

30

36

189

Loss on disposal of assets

-

-

-

-

-

-61

5

-23

-9

-

-

-

-

0

0

0

-5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

208

23

21

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

5,855

4,977

-977

1,823

3,868

6,132

-5,738

3,251

5,102

3,122

2,627

3,934

1,757

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other receivables

842

628

524

-2,871

2,113

975

-262

83

-184

54

249

-1,075

622

-148

45

557

-855

1,432

-1,302

762

-218

-175

-181

-322

892

-211

160

376

180

-

-

-

-

-

-

-

-

Inventory

37

1,311

699

-830

557

-462

-682

-959

177

-633

-282

2,128

-201

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

3,520

-2,762

2,861

-5,235

3,015

5,776

2,129

-198

4,563

-6,100

6,513

1,172

-674

1,844

-1,736

2,516

2,107

22

842

-152

92

-959

-954

1,188

73

286

1,025

-588

761

233

201

-37

-438

288

-40

-230

113

Operating lease right-of-use assets

-1,187

-1,019

-1,723

-300

-833

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-18

59

-28

35

-105

347

-47

-33

-31

-15

-153

-146

-117

-190

-136

-129

911

-76

72

55

-9

109

67

-32

-36

-

-

-

-

-2

-4

-4

-4

-64

-7

-9

-26

Accounts payable

-599

3,778

-1,206

1,375

108

237

-333

267

-5,790

5,824

-626

1,575

-1,899

1,246

1,642

-283

-365

-488

-756

492

408

906

6

-458

1,190

-748

-57

-219

21

244

374

-277

-926

699

123

-249

-602

Accrued liabilities

24,057

3,157

4,877

-12,611

11,035

17,641

-7,053

2,557

2,849

7,063

-4,110

-1,663

2,916

1,489

7,089

7,772

-771

4,685

-1,073

2,602

42

3,690

1,922

1,777

-123

-118

182

2,329

20

-547

-539

532

1,189

-898

389

-240

1,026

Deferred revenue

-

-

-

-

-

-

-

-

-

0

0

-4,132

1,488

-

-

-

-

-

-

-

-

-15

-14

-13

-13

-25

-31

-29

-294

168

-2,905

-13

-72

107

-85

224

-303

Operating lease liabilities

-360

-448

-993

-139

-938

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

376

687

761

401

-352

349

183

244

591

-54

-17

38

67

-20

-20

-20

-15

-7

-101

122

83

114

3

5

5

-

-

-

-

-

-

-

-

-24

-23

-22

-23

Net cash used in operating activities

-49,002

-29,707

-18,851

-38,397

-64,175

-39,079

-42,280

-40,875

-45,236

-29,895

-58,401

-58,900

-70,561

-61,189

-49,262

-56,745

-41,212

-34,722

-31,853

-29,874

-25,346

-17,801

-17,484

-16,967

-14,182

-10,265

-9,475

-5,444

-6,585

-6,297

-5,306

-4,800

-5,230

-5,338

-4,172

-5,280

-5,107

Cash flows from investing activities
Purchases of investment securities

100,773

317,775

84,182

102,732

73,945

232,535

9,617

59,417

26,345

124,978

103,833

109,261

140,746

90,487

266,239

86,063

240,566

53,560

90,671

75,609

49,646

28,150

18,572

137,718

150,921

24,829

24,724

107,165

54,867

41,119

5,771

5,788

4,050

8,252

6,658

8,809

24,347

Maturities of investment securities

131,315

108,838

94,185

113,379

97,525

44,116

42,411

58,740

116,411

106,892

123,221

147,824

194,166

159,876

111,801

87,183

72,077

110,578

99,165

120,347

89,107

68,720

57,525

70,208

51,815

34,498

21,196

8,620

21,773

6,065

2,878

14,087

7,918

12,067

11,139

15,231

15,612

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

3

8

0

355

-94

-9

-

-

-

-

Purchases of property and equipment

934

207

80

20

822

570

1,015

115

448

7

56

264

485

249

470

580

207

293

186

674

988

94

80

0

6

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

29,608

-209,144

9,923

10,627

22,758

-188,949

31,784

-3,942

89,618

-18,093

19,332

38,299

52,935

69,140

-154,908

-7,460

-168,696

56,725

8,308

44,064

38,473

40,476

38,873

-67,510

-99,112

9,541

-3,943

-98,616

-33,086

-35,054

-2,744

8,393

3,877

3,815

4,478

6,422

-8,735

Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs

3,754

43,058

319,967

4,646

4,176

300,603

211

2,953

2,880

4,791

7,897

7,010

11,490

3,390

226,077

6,438

282,991

9,377

1,132

2,599

1,439

2,807

1,282

1,720

198,042

629

974

109,871

208

91,237

6,869

67

31

106

2

61

13,853

Repayments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

9

10

9

9

12

14

43

Net cash provided by financing activities

3,754

43,058

319,967

4,646

4,176

300,603

211

2,953

2,880

4,791

7,897

7,010

11,490

3,986

226,077

20,758

282,991

9,332

1,132

2,599

1,439

2,807

1,282

1,720

198,042

629

974

109,871

208

91,233

6,860

57

22

97

-10

47

13,810

Effect of exchange rate changes on cash

2

-

-

-

1

1

0

4

-2

-1

-1

-3

-1

-

-

-

-1

4

0

-1

4

-

-

-

-

-

-

-

-

-

-

-

-

-2

1

2

12

Net decrease in cash, cash equivalents and restricted cash

-15,638

-195,794

311,042

-23,125

-37,240

72,576

-10,285

-41,860

47,260

-43,198

-31,173

-13,594

-6,137

11,941

21,905

-43,446

73,082

31,339

-22,413

16,788

14,570

25,485

22,671

-82,757

84,748

-96

-12,444

5,811

-39,463

49,883

-1,192

3,650

-1,331

-1,428

297

1,191

-20

Supplemental disclosure of noncash information:
Property and equipment purchases in accounts payable and accrued liabilities

1,269

-7

24

-4

21

-

-

-

-

0

-34

-132

175

-67

33

-102

356

-

-

-

367

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation capitalized in inventory

-

-

-

-

-

-

-

-

-158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-